Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-127-2013

Drug recall · January 23, 2013

Divalproex Sodium Delayed-Release Tablets recall

Why: Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.

Lots / codes

Lot #: 310162, Exp 09/14

Quantity
11,316 bottles
Company
Upsher Smith Laboratories, Inc., Maple Grove, MN
Distribution
Nationwide and Puerto Rico
Initiated
December 10, 2012 · Voluntary: Firm initiated
Classified
January 16, 2013
Reported
January 23, 2013
Ended
November 19, 2013
How notified
Telephone

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.